BELLINI
Nov 05, 2020•15 min
Episode description
The BELLINI trial of venetoxlax in multiple myeloma was put on hold last year due to increased mortality. It's now published (https://doi.org/10.1016/S1470-2045(20)30525-8), so we take a look at the data and the myriad of supportive care concerns.
For the best experience, listen in Metacast app for iOS or Android
